Proxima Raises $80 Million Led by DCVC to Power the Next Generation of Proximity-Based Medicines
NEW YORK & BOSTON–(BUSINESS WIRE)–Proxima (formerly VantAI), the AI-native biotech company pioneering the next generation of AI-driven drug discovery for proximity therapeutics, today announced an oversubscribed $80M seed financing. The round was led by DCVC, with…
